Ana Tiganescu

5PUBLICATIONS
201CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples and disabilityMolecular targetsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 24, 2026
Mortality risk and causes of death in exogenous Cushing's syndrome: a systematic review and meta-analysis.

Padiporn Limumpornpetch, Paul M Stewart, Mar Pujades-Rodriguez

|Sep 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement.

Emma Short, Ian M Adcock, Bilal Al-Sarireh

|Mar 29, 2024
Inhibition of the glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 drives concurrent 11-oxygenated androgen excess.

Lina Schiffer, Imken Oestlund, Jacky L Snoep

|Apr 29, 2022
The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality.

Padiporn Limumpornpetch, Ann W Morgan, Ana Tiganescu

|Feb 03, 2022
Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial.

R A Ajjan, E M A Hensor, F Del Galdo

Pageof 1

Frequent Collaborators

2 joint publications

Wiebke Arlt

2 joint publications

Padiporn Limumpornpetch

2 joint publications

Ann W Morgan

2 joint publications

Paul D Baxter